Does the AMH Concentration Depend on the Menstrual Cycle?
NCT06330259 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-04-01
Summary
During two none subsequent natural menstrual cycles healthy female participants will be subjected every second day to blood sampling and 3D-ultrasound examinations. Together with four other key hormones the concentration of AMH (anti-Muellerian Hormone) will be measured in the serum.
Conditions
- Reproductive Sterility
Interventions
- DIAGNOSTIC_TEST
-
menstrual cycle monitoring
frequent serum sampling and 3D ultrasound
Sponsors & Collaborators
-
Roche Diagnostics GmbH
collaborator INDUSTRY -
University of Basel
lead OTHER
Principal Investigators
-
Christian De Geyter, MD · University of Basel
Eligibility
- Min Age
- 18 Years
- Max Age
- 39 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2018-06-30
- Completion
- 2019-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old
NCT01219387 ·Status: COMPLETED
-
Antimullerian Hormone as an Indicator for Ovarian Response
NCT03291860 ·Status: UNKNOWN
-
Anti-Müllerian Hormone is Not Predictive of Pregnancy in Donor Insemination Cycles in Non-infertile Women
NCT03160872 ·Status: COMPLETED
-
AMH and Pregnancy Outcome in IVF
NCT04512807 ·Status: UNKNOWN
-
Hormones in Hypogonadotropic Hypogonadism
NCT04927676 ·Status: RECRUITING
-
AMH and Dosing Regimens for Initial IVF Stimulation Protocols
NCT03098199 ·Status: COMPLETED ·Phase: NA
-
Daytime Profile of Salivary Progesterone
NCT03725904 ·Status: COMPLETED ·Phase: NA
-
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
NCT02595255 ·Status: RECRUITING
-
Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response
NCT04168892 ·Status: COMPLETED
-
Anti-Mullerian Hormone (AMH) and Antral Follicle Count as Markers of Ovarian Reserve- Prospective Followup of Young Cancer Patients
NCT00930501 ·Status: UNKNOWN
-
Serial Progesterone Level Measurements During the Menstrual Cycle in Subfertile Women
NCT05211583 ·Status: UNKNOWN
-
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
NCT01340521 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
HIV and Ovarian Reserve
NCT03572270 ·Status: UNKNOWN ·Phase: NA
-
What is the Best Moment for Performing an HSG in Women With a Unfulfilled Childwish
NCT05608590 ·Status: RECRUITING ·Phase: PHASE4
-
AMH Levels Change During Treatment With GnRh Agonist
NCT02086279 ·Status: COMPLETED ·Phase: NA
-
Relationship Between Fertility Hormone Patterns and Pregnancy Rates.
NCT05033366 ·Status: ENROLLING_BY_INVITATION
-
Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles
NCT06263192 ·Status: COMPLETED
-
Inhibin B/AFC Ratio for Ovarian Response
NCT06292806 ·Status: NOT_YET_RECRUITING
-
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
NCT01206803 ·Status: COMPLETED
-
Individualization of Ovarian Stimulation Using AMH Maximizes the Benefits and Minimizes Complications and Risks
NCT01887652 ·Status: COMPLETED ·Phase: NA
-
Stop Menstruation and Pregnancy Rates in Antagonist Protocol
NCT01357473 ·Status: COMPLETED
-
Whole-Brain Dynamics in the Natural Menstrual Cycle vs. an Ovarian Stimulated Cycle: Impact of Hormonal Fluctuations on Healthy Women Undergoing Ovarian Stimulation
NCT06910293 ·Status: RECRUITING
-
Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction
NCT03507673 ·Status: RECRUITING
-
Androgenic Profile Following Controlled Ovarian Stimulation
NCT02992808 ·Status: UNKNOWN ·Phase: PHASE4
-
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
NCT03607409 ·Status: COMPLETED